date,title,source
Oct-17-18,Albireo Receives FDA Fast Track Designation for A4250,GlobeNewswire
Oct-26-18,"Report: Exploring Fundamental Drivers Behind Manulife Financial, Baozun, AstraZeneca, Insight Enterprises, Albireo Pharma, and Mobile TeleSystems OJSC  New Horizons, Emerging Trends, and Upcoming Developments",GlobeNewswire
Nov-08-18,Albireo to Present at Investor Conferences in November,GlobeNewswire
Nov-13-18,Albireo Reports Third Quarter 2018 Financial Results,GlobeNewswire
Dec-18-18,Albireo Granted Orphan Designation by European Commission For Lead Product Candidate A4250 for Treatment of Biliary Atresia,GlobeNewswire
Feb-07-19,"How Financially Strong Is Albireo Pharma, Inc. (NASDAQ:ALBO)?",Simply Wall St.
Feb-25-19,"New Research Coverage Highlights Starbucks, Cheetah Mobile, Seagate Technology, Momo, Albireo Pharma, and Essent Group  Consolidated Revenues, Company Growth, and Expectations for 2019",GlobeNewswire
Feb-28-19,Albireo Recognizes Rare Disease Day and Highlights Urgent Need to Support Families Affected by Progressive Familial Intrahepatic Cholestasis (PFIC),GlobeNewswire
Mar-04-19,Albireo to Present at Cowen and Company 39th Annual Health Care Conference,GlobeNewswire
Mar-07-19,"Albireo Pharma, Inc. (ALBO) Q4 2018 Earnings Conference Call Transcript",Motley Fool
Mar-07-19,Albireo Reports Year-End 2018 Financial Results and Provides Pipeline Update,GlobeNewswire
Mar-21-19,Albireo Expands Executive Leadership Team with Appointment of Pamela Stephenson as Chief Commercial Officer,GlobeNewswire
